# ABREVA

NDC: 0135-0200
Generic name: docosanol
Labeler / Manufacturer: Haleon US Holdings LLC
Product type: HUMAN OTC DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CREAM
Routes: TOPICAL
Marketing started: 20100319

FDA application: NDA020941

## Active ingredients

- DOCOSANOL: 100 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0135-0200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0135-0200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c39b38a7-dcdd-4c32-8f35-b565c4d3cec6